Monogenic ion channelopathies of the skeleton

被引:1
|
作者
Stauber, T. [1 ]
Horn, D. [2 ]
Kornak, U. [2 ]
机构
[1] Leibniz Inst Mol Pharmakol FMP Berlin, Berlin, Germany
[2] Charite, Inst Med Genet & Humangenet, D-13351 Berlin, Germany
关键词
Calcium channels; Chloride channels; Connexins; Chondrodysplasia; Osteopetrosis; AUTOSOMAL-DOMINANT OSTEOPETROSIS; RECESSIVE OSTEOPETROSIS; REQUIRES OSTM1; MUTATION; DISEASE; PROTEIN; CIC-7; TRPV4; LEADS;
D O I
10.1007/s11825-013-0420-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Although ion channels are intuitively more related to the generation of action potentials, they can influence skeletal cells, development, and homeostasis in different ways as demonstrated in this review. All major skeletal cell types, chondrocytes, osteoblasts, osteocytes, and osteoclasts, can be involved in the pathogenesis and often the interaction of these different defects is incompletely understood. Connexin 43 and TRPV4, two of the mentioned membrane proteins, predominantly conduct calcium ions and are the basis of a whole spectrum of skeletal phenotypes. While connexin 43 seems to regulate the function of osteoblasts and osteocytes, TRPV4 is crucial for chondrocytes. The other two examples are chloride-transporting membrane proteins ANO5 and ClC-7, which can cause gnathodiaphyseal dysplasia and osteopetrosis, respectively. Whereas the function of ANO5 is largely unknown, the role of ClC-7 in bone resorbing osteoclasts has been investigated in great detail.
引用
收藏
页码:493 / 500
页数:8
相关论文
共 50 条
  • [21] Role of Pharmacotherapy in Cardiac Ion Channelopathies
    El-Sherif, Nabil
    Pedalino, Ronald
    Himel, Herman
    CURRENT VASCULAR PHARMACOLOGY, 2009, 7 (03) : 358 - 366
  • [22] Role of pharmacotherapy in cardiac ion channelopathies
    El-Sherif, Nabil
    Boutjdir, Mohamed
    PHARMACOLOGY & THERAPEUTICS, 2015, 155 : 132 - 142
  • [23] Biophysics of the cochlea - biomechanics and ion channelopathies
    Ashmore, J
    BRITISH MEDICAL BULLETIN, 2002, 63 : 59 - 72
  • [24] Physiologic principles underlying ion channelopathies
    Cannon, Stephen C.
    NEUROTHERAPEUTICS, 2007, 4 (02) : 174 - 183
  • [25] Teaching course: ion channelopathies in neurology
    Karin Jurkat-Rott
    Holger Lerche
    Nenad Mitrovic
    F. Lehmann-Horn
    Journal of Neurology, 1999, 246 : 758 - 763
  • [26] Special Issue: "Recent Advances in Ion Channels and Ion Channelopathies"
    Hryciw, Deanne H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [27] Editorial: Reviews in pharmacology of ion channels and channelopathies
    Zhang, Jinwei
    Sabatier, Jean-Marc
    Chahine, Mohamed
    Tricarico, Domenico
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] Drug repurposing in skeletal muscle ion channelopathies
    Altamura, Concetta
    Saltarella, Ilaria
    Campanale, Carmen
    Laghetti, Paola
    Desaphy, Jean-Francois
    CURRENT OPINION IN PHARMACOLOGY, 2023, 68
  • [29] Role of ion channels in heart failure and channelopathies
    Rahm A.-K.
    Lugenbiel P.
    Schweizer P.A.
    Katus H.A.
    Thomas D.
    Biophysical Reviews, 2018, 10 (4) : 1097 - 1106
  • [30] Ion channelopathies: a tapped-out mine?
    Dudley, Samuel C., Jr.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2011, 300 (03): : H716 - H717